Cargando…
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
We report the discovery of several highly potent small molecules with low-nM potency against severe acute respiratory syndrome coronavirus (SARS-CoV; lowest half-maximal inhibitory concentration (IC(50): 13 nM), SARS-CoV-2 (IC(50): 23 nM), and Middle East respiratory syndrome coronavirus (MERS-CoV;...
Autores principales: | Curreli, Francesca, Ahmed, Shahad, Victor, Sofia M. B., Drelich, Aleksandra, Panda, Siva S., Altieri, Andrea, Kurkin, Alexander V., Tseng, Chien-Te K., Hillyer, Christopher D., Debnath, Asim K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780828/ https://www.ncbi.nlm.nih.gov/pubmed/35062273 http://dx.doi.org/10.3390/v14010069 |
Ejemplares similares
-
Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro
por: Curreli, Francesca, et al.
Publicado: (2020) -
Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors
por: Curreli, Francesca, et al.
Publicado: (2023) -
Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors that Potently Reactivate Latent HIV
por: Curreli, Francesca, et al.
Publicado: (2020) -
Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model
por: Stoddart, Cheryl A., et al.
Publicado: (2022) -
Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists
por: Curreli, Francesca, et al.
Publicado: (2022)